I am entering $CELZ at $0.011. It looks undervalued. Scheduled for launch in January 2019, CaverStem(TM) will increase its online presence on Social Media by sponsorships and banner advertising on websites and search engines attracting the active male. The company successfully sponsored the treatment of two patients in Moscow using the CaverStem(TM) procedure. Treatment of patients is ongoing with positive results and is anticipated to steadily increase in 2019. Physicians in Switzerland and Italy are being scheduled for training and patients are being recruited.